ABAzyne Biosciences

ABAzyne BioScience Inc. is a Canadian agriculture biotech company specializing in the development of patented synthetic Abscisic Acid (ABA) analogs for plant growth regulation. The company leverages over 30 years of research conducted in collaboration with the National Research Council of Canada and the University of Saskatchewan, along with industry, academia, and producer-based partnerships. ABAzyne's core product portfolio includes ABA antagonists like ABA 1019 and HyperABA, which promote seed germination under stress conditions and enhance plant growth by resisting plant enzymes. The company primarily serves agricultural producers and researchers looking to improve crop yields and resilience. ABAzyne operates in the agricultural biotechnology market, focusing on innovation and research-driven solutions. The business model revolves around the development and commercialization of its patented ABA analogs, generating revenue through product sales and licensing agreements.

Keywords: synthetic Abscisic Acid, plant growth regulation, agricultural biotech, crop resilience, seed germination, ABA antagonists, HyperABA, research-driven, patented solutions, Canadian innovation.